COPEGUS

This brand name is authorized in Estonia, Hong Kong, Lithuania, Poland, Singapore, South Africa

Active ingredients

The drug COPEGUS contains one active pharmaceutical ingredient (API):

1 Ribavirin UNII 49717AWG6K - RIBAVIRIN

Ribavirin is a synthetic nucleoside analogue which has shown in vitro activity against some RNA and DNA viruses. The mechanism by which ribavirin in combination with other medicinal products exerts its effects against HCV is unknown. Read about Ribavirin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AP01		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections
Discover more medicines within J05AP01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1161414, 1161425, 1161436, 1161447
Country: HK	Department of Health Drug Office	Identifier(s): 56500
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003792, 1016294, 1016295, 1016296, 1022591, 1022592, 1069907, 1071141
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100157891, 100175080
Country: SG	Health Sciences Authority	Identifier(s): 12443P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 38/20.2.8/0181, 41/20.2.8/0141